Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Recommendations and Price Targets for Cencora and AmerisourceBergen

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Finance_Assets (2)
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On February 26, 2024, analyst Michael Cherny of Leerink Partners kicked off coverage on Cencora (NYSE: COR) with an optimistic Outperform rating and a target price of $261. This endorsement suggests that Cherny sees potential for Cencora to outperform the market. Meanwhile, UBS raised AmerisourceBergen’s price target to $225 from $200, affirming their Buy rating and showing faith in the company’s future performance. SVB Leerink has also provided stock recommendations and price targets for Cencora, highlighting the significance of analyst assessments for investors evaluating investment opportunities.

CoreSite Realty Corporation (COR) Shows Strong Performance in Stock Market on February 26, 2024

On February 26, 2024, CoreSite Realty Corporation (COR) had a strong performance in the stock market. According to data from CNN Money, COR was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the past year and is in a bullish trend.

The price of COR shares increased by $1.40 since the market last closed, representing a 0.59% rise. The stock opened at $239.04, which was $1.77 higher than its previous close. This opening price indicated a positive start to the trading day for COR investors.

The strong performance of COR on February 26th can be attributed to several factors. The overall market sentiment may have been positive, leading to increased buying interest in the stock. Additionally, company-specific news or developments could have contributed to the stock’s price momentum.

COR Stock Shows Strong Financial Performance with Revenue and Net Income Growth in Q1 2024

On February 26, 2024, COR stock had a strong performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $262.17 billion for the past year, representing a 9.89% increase compared to the previous year. In the first quarter of the current year, total revenue was reported at $72.25 billion, showing a 4.83% increase from the previous quarter.

Net income for the past year was $1.75 billion, which remained flat compared to the previous year. However, in the first quarter of the current year, net income increased significantly by 71.58% to $601.50 million. This improvement in net income is a positive sign for investors and indicates that the company is managing its expenses effectively.

Earnings per share (EPS) for the past year were reported at $8.53, showing a 6.06% increase compared to the previous year. In the first quarter of the current year, EPS increased by 72.9% to $2.98. This significant increase in EPS reflects the company’s strong financial performance and profitability.

Overall, the financial data for COR stock on February 26, 2024, indicates a positive trend in terms of revenue, net income, and earnings per share. Investors may view this as a good opportunity to consider investing in COR stock, as the company’s performance continues to improve. It is important for investors to conduct further research and analysis before making any investment decisions.

Tags: COR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Advancing Universal CAR Technology for Autoimmune Disorders

Finance_Budgeting (1)

Anticipation Builds for Nelnets Quarterly Earnings Report

Finance_Fiscal (2)

Earnings Forecast and Stock Performance for Ovintiv

Recommended

Eli Lilly Stock

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

3 months ago
Applovin Stock

Regulatory Storm Clouds Gather Over Applovin

4 months ago
Apple Stock

Berkshire’s Apple Share Sale Sparks Market Speculation Ahead of Key Launch

5 months ago
Asml Stock

Is ASML Stock Presenting a Major Buying Opportunity?

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Trending

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

by Jackson Burston
February 7, 2026
0

In late January 2026, ServiceNow reported quarterly financial results that surpassed even the most optimistic projections from...

Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com